Remove Ischemia Remove Peripheral Arterial Disease Remove Research
article thumbnail

Esperion Presents New Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL

DAIC

18, 2024 — In November, Esperion presented an analysis from the CLEAR Outcomes study focused on patients with Peripheral Artery Disease (PAD) who were unable or unwilling to take statin medications. Bonaca, MD, MPH, FAHA, FACC, CPC Clinical Research. tim.hodson Tue, 12/03/2024 - 16:52 Nov.

article thumbnail

Long‐Term Outcomes of Peripheral Artery Disease in Veterans: Analysis of the Peripheral Artery Disease Long‐Term Survival Study (PEARLS)

Journal of the American Heart Association

Study end points include mortality, cardiovascular events (hospitalization for acute myocardial infarction or stroke) and limb events (hospitalization for critical limb ischemia or major amputation) and were identified using Veterans Affairs and nonVeterans Affairs encounters.ResultsThe mean age was 70.6 were male, and 18.5%

article thumbnail

New studies reveal underrepresentation of women and Hispanic population in the treatment of peripheral artery disease

Medical Xpress - Cardiology

New study findings underscore gaps in clinical trial representation of women and Hispanics for peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI) research. All studies were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.

article thumbnail

ICAM1 blockade improves ischemic muscle reperfusion in diabetic mice

Cardiovascular Diabetology

Chronic Limb-Threatening Ischemia (CLTI) represents the most advanced stage of Peripheral Artery Disease (PAD) and is associated with dire prognosis, characterized by a substantial risk of limb amputation and.

article thumbnail

FFRCT Slashes PAD + CAD Mortality

CardiacWire

A study in the Journal of Vascular Surgery revealed that adding FFRCT assessments to patient workups prior to peripheral artery disease surgeries has a massive impact on coronary artery disease detection, treatments, and long-term outcomes.

article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11 35 In a large multicenter double-blind randomized trial (LoDoCo2) involving 5,522 patients with clinically stable coronary artery disease, almost all of them on statin therapy, colchicine, 0.5

article thumbnail

Study: Disparities in Peripheral Artery Disease Treatment Lead to Amputation

DAIC

tim.hodson Mon, 01/13/2025 - 16:24 A new studyreports persistent disparities in outcomes for people with peripheral artery disease (PAD) and its more severe form, chronic limb-threatening ischemia (CLTI) in the United States. had lower extremity arterial testing, and 38.7%